EcoDrugPlus

Interleukin 1 Receptor Associated Kinase 4

Ensembl ID : ENSPKIG00000023007
Gene Symbol: IRAK4
4 Cross references
202 Possible Orthologues:

Interleukin-8-Like

Ensembl ID : ENSPKIG00000016274
Gene Symbol: LOC111836794
3 Cross references
182 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 1

Ensembl ID : ENSPKIG00000014476
Gene Symbol: IDH1
3 Cross references
234 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 2

Ensembl ID : ENSPKIG00000021189
Gene Symbol: IDH2
3 Cross references
205 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 2

Ensembl ID : ENSPKIG00000020516
Gene Symbol: IDH2
2 Cross references
205 Possible Orthologues:

Kelch Like Ech Associated Protein 1

Ensembl ID : ENSPKIG00000010365
Gene Symbol: KEAP1
3 Cross references
189 Possible Orthologues:

Kinase Insert Domain Receptor

Ensembl ID : ENSPKIG00000003143
Gene Symbol: KDR
3 Cross references
197 Possible Orthologues:

Kinesin Family Member 11

Ensembl ID : ENSPKIG00000001508
Gene Symbol: KIF11
3 Cross references
202 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSPKIG00000018136
Gene Symbol: KIF5B
2 Cross references
7 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSPKIG00000011213
Gene Symbol: KIF5B
3 Cross references
281 Possible Orthologues:

Leukotriene A-4 Hydrolase-Like

Ensembl ID : ENSPKIG00000021797
Gene Symbol: LOC111858598
4 Cross references
139 Possible Orthologues:

Leukotriene A4 Hydrolase

Ensembl ID : ENSPKIG00000001490
Gene Symbol: LTA4H
4 Cross references
205 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).